[HTML][HTML] Cetuximab-containing combinations in locally advanced and recurrent or metastatic head and neck squamous cell carcinoma

M Taberna, M Oliva, R Mesía - Frontiers in oncology, 2019 - frontiersin.org
cetuximab vs. CRT in Human Papillomavirus (HPV)-positive LA oropharyngeal squamous
cell carcinoma … -free survival for RT-cetuximab combination, and therefore CRT with cisplatin …

Cetuximab: a review of its use in squamous cell carcinoma of the head and neck and metastatic colorectal cancer

SKA Blick, LJ Scott - Drugs, 2007 - Springer
… Phase I study of antiepidermal growth factor receptor antibody cetuximab in combination with
radiation therapy in patients with advanced head and neck cancer. J Clin Oncol 2001 Jul 1; …

[HTML][HTML] Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

JA Bonner, PM Harari, J Giralt, N Azarnia… - … England Journal of …, 2006 - Mass Medical Soc
… in squamous-cell carcinoma. In a preliminary study of radiotherapy plus cetuximab in patients
Cetuximab as a single agent or combined with cisplatin was also associated with clinically …

Efficacy of cetuximab in the treatment of squamous cell carcinoma

S Preneau, E Rio, A Brocard, L Peuvrel… - Journal of …, 2014 - Taylor & Francis
… In this study, the use of cetuximab combined with radiotherapy … ' argue for the use of cetuximab
combined with radiotherapy. … with cetuximab in advanced cutaneous SCC, combined with …

[HTML][HTML] Cetuximab in combination therapy: from bench to clinic

DE Gerber, H Choy - Cancer and Metastasis Reviews, 2010 - Springer
cell carcinoma xenografts for up to 100 days. In contrast, animals receiving either cetuximab
combination treatment leads to the redistribution of cells to more radiosensitive points of the …

Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head …

J Bourhis, F Rivera, R Mesia, A Awada… - Journal of clinical …, 2006 - ascopubs.org
… (FU) combinationcetuximab to this standard combination. FU dose escalation was carried
out as part of the study to determine the maximum-tolerated dose to use for the combination in …

Effect of adding motolimod to standard combination chemotherapy and cetuximab treatment of patients with squamous cell carcinoma of the head and neck: the …

RL Ferris, NF Saba, BJ Gitlitz, R Haddad… - JAMA …, 2018 - jamanetwork.com
… Platinum-based chemotherapy, fluorouracil, and cetuximab combination treatment is the
standard of care for first-line recurrent and/or metastatic (R/M) squamous cell carcinoma of the …

[HTML][HTML] The role of cetuximab for the treatment of squamous cell carcinoma of the head and neck

R Mehra, RB Cohen, BA Burtness - Clinical advances in …, 2008 - ncbi.nlm.nih.gov
… A number of studies have shown that cetuximab may be combined safely with platinum regimens
… and support the conclusion that cetuximab monotherapy rather than the combination of …

[HTML][HTML] … for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head …

L Licitra, R Mesia, F Rivera, E Remenar, R Hitt… - Annals of …, 2011 - Elsevier
… The phase III EXTREME study demonstrated that combining cetuximab with platinum/5-…
of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M …

Cetuximab: a review of its use in squamous cell carcinoma of the head and neck

JE Frampton - Drugs, 2010 - Springer
… Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil
in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. J Clin …